End the Vaccine Carveout Act

Increased lawsuit costs would likely be passed to consumers and insurance companies through higher vaccine prices. This could make vaccines less affordable and accessible to lower-income families.

Greater liability risk might discourage companies from developing new vaccines, especially for rare diseases with small markets. This could slow innovation in vaccine technology and pandemic preparedness.

Without current protections, manufacturers could face numerous lawsuits without scientific evidence linking vaccines to injuries. Courts and companies would spend resources defending against claims that lack medical basis.

Uncertainty about legal liability could create vaccine hesitancy among manufacturers and healthcare providers. This might reduce vaccination rates and weaken disease prevention efforts.